nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical Universitynefr-24Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESОсобенности синдрома анемии при хронической болезни почек у детей (обзор литературы)Features of syndrome anemia in children with chronic kidney diseaseЛысоваЕ. В.LysovaE. V.lva-elena@rambler.ruСавенковаН. Д.SavenkovaN. D.noemail@neicon.ruСанкт-Петербургский государственный педиатрический университетRussian Federation2014010520141833444Copyright © Лысова Е.В., Савенкова Н.Д., 20142014Лысова Е.В., Савенкова Н.Д.Lysova E.V., Savenkova N.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/24

В обзоре литературы обобщены особенности этиологии, механизмы развития и течения синдрома анемии при хронической болезни почек у детей.

Literature review summarizes features of etiology, mechanisms of development syndrome anemia in children with chronic kidney disease.

синдром анемиихроническая болезнь почекэритропоэтингепсидиндети. ABSTRACTHIF-1 αsyndrome anemiachronic kidney diseaseerythropoietinHIF-1ahepsidinchildrenReferencesKoshy SM, Geary DF. Anemia in children with chronic kidney disease. Pediatr Nephrol 2008; 23: 209-219Koshy SM, Geary DF. Anemia in children with chronic kidney disease. Pediatr Nephrol 2008; 23: 209-219The National Institute for Health and Clinical Excellence (NICE). National costing report: anaemia management in people with CKD. Implementing NICE guidance in England. Issued: February 2011. This updates and replaces NICE clinical guideline 39The National Institute for Health and Clinical Excellence (NICE). National costing report: anaemia management in people with CKD. Implementing NICE guidance in England. Issued: February 2011. This updates and replaces NICE clinical guideline 39Папаян АВ, Жукова ЛЮ. Анемии у детей: руководство для врачей. Питер, СПб., 2001:351-358Папаян АВ, Жукова ЛЮ. Анемии у детей: руководство для врачей. Питер, СПб., 2001:351-358KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements (2012);2:331-335KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements (2012);2:331-335Наумова В.И., Папаян А.В. Почечная недостаточность у детей. Медицина, Л., 1991;177 -189Наумова В.И., Папаян А.В. Почечная недостаточность у детей. Медицина, Л., 1991;177 -189Atkinson MA, Pierce CB, Zack RM et al. Hemoglobin differences by race in children with CKD. Am J Kidney Dis 2010;55(6):1009-1017Atkinson MA, Pierce CB, Zack RM et al. Hemoglobin differences by race in children with CKD. Am J Kidney Dis 2010;55(6):1009-1017VanDeVoorde R, Warady BA. Management of Chronic Kidney Disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, eds. Pediatric Nephrology , 6th. Heidelberg: Springer, Berlin, 2009;(2):1660-1692VanDeVoorde R, Warady BA. Management of Chronic Kidney Disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, eds. Pediatric Nephrology , 6th. Heidelberg: Springer, Berlin, 2009;(2):1660-1692Atkinson MA, Furth SL. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011; 7:635-641Atkinson MA, Furth SL. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011; 7:635-641Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother 2013;40(5):302-309Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother 2013;40(5):302-309Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med 2007; 85(12):1325-1330Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med 2007; 85(12):1325-1330Hamed EA, El-Abaseri TB, Mohamed AO et al. Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study. BMC Nephrol 2012(13); 13:136Hamed EA, El-Abaseri TB, Mohamed AO et al. Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study. BMC Nephrol 2012(13); 13:136Левина А.А., Макешова А.Б., Мамукова Ю.И, и соавт. Регуляция гомеостаза кислорода. Фактор, индуцированный гипоксией (HIF) и его значение в гомеостазе кислорода. Педиатрия. Журнал им. Г.Н. Сперанского 2009;88(4): 92-97Левина А.А., Макешова А.Б., Мамукова Ю.И, и соавт. Регуляция гомеостаза кислорода. Фактор, индуцированный гипоксией (HIF) и его значение в гомеостазе кислорода. Педиатрия. Журнал им. Г.Н. Сперанского 2009;88(4): 92-97Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: 271-281Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: 271-281Gunaratnam L, Bonventre JV. HIF in kidney disease and development. J Am Soc Nephrol 2009;20(9): 1877-1887Gunaratnam L, Bonventre JV. HIF in kidney disease and development. J Am Soc Nephrol 2009;20(9): 1877-1887Hung TW, Liou JH, Yeh KT et al. Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys. Indian J Med Res 2013; 137(1): 102-110Hung TW, Liou JH, Yeh KT et al. Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys. Indian J Med Res 2013; 137(1): 102-110Kimura K, Iwano M, Higgins DF et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295(4):1023-1029Kimura K, Iwano M, Higgins DF et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295(4):1023-1029Haase VH Hypoxia-inducible factor signaling in the development of kidney fibrosis. Fibrogenesis Tissue Repair 2012;5[Supp l]:16Haase VH Hypoxia-inducible factor signaling in the development of kidney fibrosis. Fibrogenesis Tissue Repair 2012;5[Supp l]:16Bolati D, Shimizu H, Yisireyili M et al. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-кВ. BMC Nephrology 2013, 14:56Bolati D, Shimizu H, Yisireyili M et al. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-кВ. BMC Nephrology 2013, 14:56Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010;116(23): 4754-4761Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010;116(23): 4754-4761Baracco R, Saadeh S, Valentini R. Iron deficiency in children with early chronic kidney disease. Pediatric Nephrol 2011; 26(11):2077-2080Baracco R, Saadeh S, Valentini R. Iron deficiency in children with early chronic kidney disease. Pediatric Nephrol 2011; 26(11):2077-2080Atkinson MA, Pierce CB, Fadrowski JJ. Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediatr Nephrol 2012; 27(12):2275-2283Atkinson MA, Pierce CB, Fadrowski JJ. Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediatr Nephrol 2012; 27(12):2275-2283Левина АА, Казюкова ТВ, Цветаева НВ. Гепсидин как регулятор гомеостаза железа. Педиатрия. Журнал им. Г.Н. Сперанского 2008; 87(1):67-74Левина АА, Казюкова ТВ, Цветаева НВ. Гепсидин как регулятор гомеостаза железа. Педиатрия. Журнал им. Г.Н. Сперанского 2008; 87(1):67-74Park CH, Valore EV, Waring A.J. et al. Hepcidin: a urinary antibacterial peptide synthesized in the liver. J Biol Chem 2001; 276(11): 7806-7810Park CH, Valore EV, Waring A.J. et al. Hepcidin: a urinary antibacterial peptide synthesized in the liver. J Biol Chem 2001; 276(11): 7806-7810Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a antibicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002; 277(40): 37597-37603Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a antibicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002; 277(40): 37597-37603Coyne DW. Hepcidin: utility as a diagnostic tool and therapeutic target. Kidney Int 2011;80(3):240-244Coyne DW. Hepcidin: utility as a diagnostic tool and therapeutic target. Kidney Int 2011;80(3):240-244Kemma E, Pickkers P, Nemeth E et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106(5):1864-1866Kemma E, Pickkers P, Nemeth E et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106(5):1864-1866Goldstein, S L, Leung, JC, Silverstein DM. Pro- and antiinflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Clin J Am Soc Nephrol 2006; 1(5):979-986Goldstein, S L, Leung, JC, Silverstein DM. Pro- and antiinflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Clin J Am Soc Nephrol 2006; 1(5):979-986Zaritsky J, Young B, Wang HJ et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(6): 1051-1056Zaritsky J, Young B, Wang HJ et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(6): 1051-1056Malyszko J, Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res 2007; 30(1): 15-30Malyszko J, Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res 2007; 30(1): 15-30Reuter S. E., Faull R. J., Ranieri E., Evans A. M. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24(3): 990-996Reuter S. E., Faull R. J., Ranieri E., Evans A. M. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24(3): 990-996Costa E., Pereira B. J., Rocha-Pereira P. et al. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol 2008; 28(4): 677-683Costa E., Pereira B. J., Rocha-Pereira P. et al. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol 2008; 28(4): 677-683Costa E, Lima M, Alves JM et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol 2008; 28(3): 268-275Costa E, Lima M, Alves JM et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol 2008; 28(3): 268-275Al-Hilali N, Al-Humoud H, Ninan VT et al. Does parathyroid hormone affect erythropoietin therapy in dialysis patients? Med Princ Pract 2007; 16(1): 63-67Al-Hilali N, Al-Humoud H, Ninan VT et al. Does parathyroid hormone affect erythropoietin therapy in dialysis patients? Med Princ Pract 2007; 16(1): 63-67Pronai W, Riegler-Keil M, Silberbauer K, Stockenhuber F. Folic acid supplementation improves erythropoietin response. Nephron 1995;71(4): 395-400Pronai W, Riegler-Keil M, Silberbauer K, Stockenhuber F. Folic acid supplementation improves erythropoietin response. Nephron 1995;71(4): 395-400Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr. Nephrol 2010; 25(9): 1699-1706Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr. Nephrol 2010; 25(9): 1699-1706Добронравов ВА, Смирнов AB, Безруких АМ и соавт. Анемия и преддиализные стадии хронической болезни почек: клиническое значение, распространенность и факторы. Нефрология 2006;10(3): 7-13Добронравов ВА, Смирнов AB, Безруких АМ и соавт. Анемия и преддиализные стадии хронической болезни почек: клиническое значение, распространенность и факторы. Нефрология 2006;10(3): 7-13Fadrowski JJ, Pierce CB, Cole SR et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008;3(2): 457-462Fadrowski JJ, Pierce CB, Cole SR et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008;3(2): 457-462Hollowell JG, Van Assendelft OW, Gunter EW et al. Hematological and iron-related analytes - reference data for persons aged 1 year and over: United States, 1988-1994. Vital Health Stat 11, 2005;(247):1-156Hollowell JG, Van Assendelft OW, Gunter EW et al. Hematological and iron-related analytes - reference data for persons aged 1 year and over: United States, 1988-1994. Vital Health Stat 11, 2005;(247):1-156Staples AO, Wong CS, Smith JM et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(1): 48-56Staples AO, Wong CS, Smith JM et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(1): 48-56Mc Clellan W, Aronoff SL, Bolton WK at al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Ress Opion 2004; 20(9): 1501-1510Mc Clellan W, Aronoff SL, Bolton WK at al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Ress Opion 2004; 20(9): 1501-1510Жетишев PA, Мамбетова АМ. Анемический синдром у детей и подростков с хронической почечной недостаточностью. Педиатрия. Журнал им. Г.Н. Сперанского 2005;4:39-41Жетишев PA, Мамбетова АМ. Анемический синдром у детей и подростков с хронической почечной недостаточностью. Педиатрия. Журнал им. Г.Н. Сперанского 2005;4:39-41Artunc F, Risler Т. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrology Dialysis Transplantation 2007; 22(10):2900-2908Artunc F, Risler Т. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrology Dialysis Transplantation 2007; 22(10):2900-2908Маковецкая ГА, Мазур ЛИ, Балашова ЕА. Особенности формирования анемии при хронической болезни почек у детей. Педиатрия. Журнал имени Г.Н. Сперанского 2009;88(3):6-12Маковецкая ГА, Мазур ЛИ, Балашова ЕА. Особенности формирования анемии при хронической болезни почек у детей. Педиатрия. Журнал имени Г.Н. Сперанского 2009;88(3):6-12Khosroshahia HTB, Shojac MMB, Tubbsd RSB et al. Serum Erythropoietin Levels and Their Correlation With the Erythropoietic System in Hemodialysis Patients and Renal Allograft Recipients. Transplant Proc 2007; 39(4):1051-1053Khosroshahia HTB, Shojac MMB, Tubbsd RSB et al. Serum Erythropoietin Levels and Their Correlation With the Erythropoietic System in Hemodialysis Patients and Renal Allograft Recipients. Transplant Proc 2007; 39(4):1051-1053Amaral S, Hwang W, Fivush B et al. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 2008; 3(3):759-767Amaral S, Hwang W, Fivush B et al. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 2008; 3(3):759-767Greenbaum LA. Anemia in Chronic Renal Disease. In: Geary DF, Schaefer F Comprehensive Pediatric Nephrology (First Edition), Mosby Elsevier Philadelphia, 2008:761-772Greenbaum LA. Anemia in Chronic Renal Disease. In: Geary DF, Schaefer F Comprehensive Pediatric Nephrology (First Edition), Mosby Elsevier Philadelphia, 2008:761-772Mitsnefes, MM. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 2006; 149(5):671-675Mitsnefes, MM. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 2006; 149(5):671-675Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66(2):753-760Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66(2):753-760Furth SL, Cole SR, Fadrowski JJ et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr Nephrol 2007; 22(2): 265-271Furth SL, Cole SR, Fadrowski JJ et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr Nephrol 2007; 22(2): 265-271Borzych-Duzalka D, Bilginer Y, Ha IS et all. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 2013;24(4):665-676Borzych-Duzalka D, Bilginer Y, Ha IS et all. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 2013;24(4):665-676

The authors declare that there are no conflicts of interest present.